san antonio roundtable, part 3: trastuzumab, bevacizumab, and angiogenesis inhibitors
Published 11 years ago • 460 plays • Length 9:17Download video MP4
Download video MP3
Similar videos
-
7:25
san antonio roundtable, part 2: calor trial, triple-negative breast cancer
-
10:55
san antonio roundtable, part 4: everolimus in clinical practice, a new cdk inhibitor
-
0:18
journey through the arteries: life’s vital highways #3danatomy
-
3:00
genes may predict trastuzumab outcomes in breast cancer
-
0:17
💓 exploring the heart: inside and out 💓 #anatomy #meded #3danimation
-
13:17
spotlight session: "three cdk 4/6 inhibitors, a lot of biomarkers, what does it all mean moving..."
-
1:31
memorial satilla health offers 3d biopsy
-
44:53
update in multiple myeloma
-
5:19
a 17-year fight against multiple myeloma
-
25:18
angiogenesis (hd)
-
3:25
bvd in heavily pretreated multiple myeloma
-
8:15
bolero-2: overcoming treatment resistance in breast cancer
-
12:44
gs3-03: "genomic analysis of 733 her2 breast cancers identifies recurrent pathways alterations..."
-
2:09
albumleaf 17, 3 jefferson pieces: no. 3. the rotunda
-
37:36
angiogenesis and angiotherapy part 3
-
15:26
gs3-04: discussant
-
15:18
gs3-07: "circulating tumor dna (ctdna) dynamics in patients with hormone receptor positive..."
-
4:21
t-cells: challenges in bringing to market
-
27:26
plenary lecture dr. melinda telli, md: recent advances in triple negative breast cancer
-
9:41
gs1-02: "randomized, double-blind, phase 3 study of pembrolizumab chemotherapy vs placebo..."
-
4:57
comics episode 32: osteoporosis